Delivery Order SPE2DB24D2018-SPE2DB25FWTU5
Award Date
3/31/25
Potential Completion Date
4/21/25
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,296.97 firm fixed-price delivery order is for the supply of TAVALISSE 150 MG TABLET 60S, a medication, with a completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an award ceiling value of $9,266.70 and is for the delivery of TAVALISSE 100 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,296.97 firm fixed-price delivery order is for the provision of TAVALISSE 150 MG TABLET 60S, with a period of performance through February 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,963.18 Firm Fixed Price delivery order contract covers the supply of TALVEY 40 MG/ML VIALML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $27,926.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 17, 2025. The contract provides for the delivery of TALVEY 40 MG/ML VIALML, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,926.36 firm fixed-price delivery order covers the supply of "TALVEY 40 MG/ML VIALML" medical products, with a performance period through March 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TAVALISSE 150 MG TABLET 60S. The delivery order, which does not have a set-aside designation, has a ceiling value of $29,240.00 and a performance period ending on June 4, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is a significant supplier of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,522.50 firm fixed-price delivery order is for the supply of TADLIQ 20 MG/5 ML SUSPENSION 150ML, a pharmaceutical product. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,641.10 firm fixed-price contract is for the delivery of TALVEY 40 MG/ML VIALML, a medical product, with a completion date of March 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award with the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,112.20 firm fixed-price delivery order is for the supply of "TALVEY 40 MG/ML VIALML" medical items, with a completion date of January 22, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...